Dubai Hosts Scientific Event Showcasing Innovations In Influenza Vaccination Techniques

Dubai recently hosted a scientific gathering organised by the American Academy of Pediatrics, in partnership with the Emirates Pediatrics and Neonatal Society. This event brought together international experts and UAE physicians to discuss recent advancements in influenza vaccination.

Dr. Entesar Al Hammadi, President of the Emirates Pediatrics and Neonatal Society, highlighted a new influenza vaccine delivered via nasal spray instead of traditional needles. This method simplifies the vaccination process, making it quicker and painless.

The nasal spray vaccine is currently approved for individuals aged 2 to 49. Ongoing research aims to extend its availability to other age groups in the future. The innovation is expected to enhance public acceptance due to its non-invasive nature.

Dr. Ahmed Al Hammadi, Infectious Diseases Consultant and Chairman of the Emirates Infectious Disease Society, emphasised that their participation in the conference and introduction of this vaccine reflect efforts to increase awareness about seasonal influenza vaccination's importance.

The initiative aims to promote safe preventive options like modern vaccines such as the nasal spray. These options offer both safety and convenience, supporting national health strategies focused on reducing influenza transmission and protecting high-risk groups.

Dr. Eslam El-Baroudy, Professor and Consultant of Paediatrics, and Chief Medical Officer at KidsHeart Centres, described the regional launch of this needle-free vaccine as a significant milestone. He noted that it can help alleviate children's fear of injections and improve parental acceptance.

Clinical Validation

Dr. El-Baroudy added that clinical studies have confirmed the safety and effectiveness of this new vaccine. Such findings are crucial for encouraging widespread adoption among parents and healthcare providers alike.

This event underscores ongoing efforts to advance public health through innovative solutions in vaccination methods. By focusing on non-invasive options, these initiatives aim to enhance community health outcomes effectively.

With inputs from WAM